-
Association of Reversal of Renin Suppression With Long-Term Renal Outcome in Medically Treated Primary Aldosteronism. Hypertension (IF 8.3) Pub Date : 2023-07-14 Sho Katsuragawa,Atsushi Goto,Satoru Shinoda,Kosuke Inoue,Kazuki Nakai,Jun Saito,Tetsuo Nishikawa,Yuya Tsurutani
BACKGROUND Renin suppression in primary aldosteronism indicates mineralocorticoid receptor activation via excessive aldosterone secretion, inducing renal damage. We investigated whether the reversal of renin suppression after the initiation of mineralocorticoid receptor antagonist therapy was associated with long-term renal outcomes in medically treated patients with primary aldosteronism. METHODS
-
Human Plasma IgG N-Glycome Profiles Reveal a Proinflammatory Phenotype in Chronic Thromboembolic Pulmonary Hypertension. Hypertension (IF 8.3) Pub Date : 2023-07-14 Ze-Jian Zhang,Hui-Fang Wang,Tian-Yu Lian,Yu-Ping Zhou,Xi-Qi Xu,Fan Guo,Yun-Peng Wei,Jing-Yi Li,Kai Sun,Chao Liu,Lu-Rong Pan,Ming Ren,Lei Nie,Hai-Long Dai,Zhi-Cheng Jing
BACKGROUND The pathological mechanism of chronic thromboembolic pulmonary hypertension (CTEPH) is not fully understood, and inflammation has been reported to be one of its etiological factors. IgG regulates systemic inflammatory homeostasis, primarily through its N-glycans. Little is known about IgG N-glycosylation in CTEPH. We aimed to map the IgG N-glycome of chronic thromboembolic pulmonary hypertension
-
Association Between Maternal Glucose Levels in Gestational Diabetes Screening and Subsequent Hypertension. Hypertension (IF 8.3) Pub Date : 2023-07-14 Xinyun Christie Liang,Anamaria Savu,Deliwe Ngwezi,Sonia Butalia,Padma Kaul,Roseanne O Yeung
BACKGROUND We assessed the association between maternal glucose levels in pregnancy and subsequent hypertension. METHODS This population-level, retrospective cohort study examined women aged 12 to 54 years with singleton pregnancies completed at ≥29 weeks of gestation from October 1, 2008 to December 1, 2018 followed until March 31, 2019 in Alberta, Canada. Women were stratified by results in the 50-gram
-
Insights Into the Role of Angiotensin-II AT1 Receptor-Dependent β-Arrestin Signaling in Cardiovascular Disease. Hypertension (IF 8.3) Pub Date : 2023-07-14 Natalia M Mathieu,Pablo Nakagawa,Justin L Grobe,Curt D Sigmund
β-arrestins are a family of intracellular signaling proteins that play a key role in regulating the activity of G protein-coupled receptors. The angiotensin-II type 1 receptor is an important G protein-coupled receptor involved in the regulation of cardiovascular function and has been implicated in the progression of cardiovascular diseases. In addition to canonical G protein signaling, G protein-coupled
-
PREPARE: A Stepped-Wedge Cluster-Randomized Trial to Evaluate Whether Risk Stratification Can Reduce Preterm Deliveries Among Patients With Suspected or Confirmed Preterm Preeclampsia. Hypertension (IF 8.3) Pub Date : 2023-07-11 Leandro De Oliveira,James M Roberts,Arundhathi Jeyabalan,Kasey Blount,Christopher W Redman,Lucilla Poston,Paul T Seed,Lucy C Chappell,Marcos Augusto Bastos Dias,
BACKGROUND Early delivery in preterm preeclampsia may reduce the risks for the patient, but consequences of prematurity may be substantial for the baby. This trial evaluated whether the implementation of a risk stratification model could safely reduce prematurity. METHODS This was a stepped-wedge cluster-randomized trial in seven clusters. Patients presenting with suspected or confirmed preeclampsia
-
Orthostatic Hypertension: A Newcomer Among the Hypertension Phenotypes. Hypertension (IF 8.3) Pub Date : 2023-07-07 Paolo Palatini
The prognostic role and the clinical significance of orthostatic hypertension (OHT) remained undefined for long because data were sparse and often inconsistent. In recent years, evidence has been accumulating that OHT is associated with an increased risk of masked and sustained hypertension, hypertension-mediated organ damage, cardiovascular disease, and mortality. Most evidence came from studies in
-
Functional and Clinical Importance of SGLT2-inhibitors in Frailty: From the Kidney to the Heart. Hypertension (IF 8.3) Pub Date : 2023-07-05 Gaetano Santulli,Fahimeh Varzideh,Imma Forzano,Scott Wilson,Luigi Salemme,Antonio de Donato,Angela Lombardi,Antonio Rainone,Luigi Nunziata,Stanislovas S Jankauskas,Tullio Tesorio,Germano Guerra,Urna Kansakar,Pasquale Mone
SGLT2 (sodium-glucose cotransporter 2) enables glucose and sodium reabsorption in the kidney. SGLT2-inhibitors (gliflozins, which include canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin) act by increasing glycosuria, thereby reducing glycemia. These drugs are critical to reach and keep glycemic control, a crucial feature, especially in patients with comorbidities, like frail individuals
-
NGAL is a Novel Target in Hypertension by Modulating the NCC-Mediated Renal Na Balance. Hypertension (IF 8.3) Pub Date : 2023-06-28 Benjamin Bonnard,Soumaya El Moghrabi,Kohei Ueda,Lionel Lattenist,Matthieu Soulie,Natalia López-Andrés,Constance Xhaard,Tatsuo Shimosawa,Patrick Rossignol,Frédéric Jaisser
BACKGROUND The expression of NGAL/lcn2 (neutrophil gelatinase-associated lipocalin) is directly modulated by mineralocorticoid receptor activation but its role in blood pressure control is unclear. METHODS a potential relationship between NGAL plasma levels, systolic blood pressure and urinary Na excretion was assessed in the STANISLAS cohort. The specific role of NGAL/lcn2 in salt-sensitive hypertension
-
Long-Term Impacts of Preeclampsia on the Cardiovascular System of Mother and Offspring. Hypertension (IF 8.3) Pub Date : 2023-06-28 Chuyu Yang,Philip N Baker,Joey P Granger,Sandra T Davidge,Chao Tong
Preeclampsia is a pregnancy-specific complication that is associated with an increased postpartum risk of cardiovascular disease (CVD) in both women and their offspring, although the underlying mechanisms have yet to be fully elucidated. Nevertheless, differential methylation of CpG islands and alterations in the expression of microRNA, associated with an elevated risk of CVD, have been observed in
-
Characterization of Individuals With Apparent Resistant Hypertension Using Contemporary Guidelines: Insights From CV-QUIC. Hypertension (IF 8.3) Pub Date : 2023-06-26 Joseph E Ebinger,Ty J Gluckman,Jose Magraner,Shih Ting Chiu,Deanna Rider,Chelsey Thomas,Sandeep R Das,P Michael Ho,Satya Shreenivas,Steven Bradley
BACKGROUND Apparent resistant hypertension (aRH) carries excess cardiovascular risk beyond nonresistant forms of hypertension; however, our understanding of this at-risk population, as defined by current US practice guidelines, is limited. Accordingly, we sought to evaluate the prevalence, clinical characteristics, and pharmacotherapeutic patterns of patients with aRH using contemporary blood pressure
-
Editors' Commentary on the 2023 ESH Management of Arterial Hypertension Guidelines. Hypertension (IF 8.3) Pub Date : 2023-06-24 Paul K Whelton,John M Flack,Garry L R Jennings,Aletta E Schutte,Ji-Guang Wang,Rhian M Touyz
Clinical practice guidelines are ideally suited to the provision of advice on the prevention, diagnosis, evaluation, and management of high blood pressure (BP). The recently published European Society of Hypertension (ESH) 2023 ESH Guidelines for the management of arterial hypertension is the latest in a long series of high BP clinical practice guidelines. It closely resembles the 2018 European Society
-
Middle-Aged and Older Patients With Left Ventricular Hypertrophy: Higher Mortality With Drug Treated Systolic Blood Pressure Below 130 mm Hg. Hypertension (IF 8.3) Pub Date : 2023-06-23 Sondre Heimark,Maria H Mehlum,Giuseppe Mancia,Camilla L Søraas,Knut Liestøl,Kristian Wachtell,Anne C Larstorp,Morten Rostrup,Julian E Mariampillai,Sverre E Kjeldsen,Stevo Julius,Michael A Weber
BACKGROUND Approximately 40% of people with hypertension have left ventricular hypertrophy (LVH) detected by ECG or echocardiography. Because patients with LVH have poor myocardial microcirculation, they may be too sensitive to lowering systolic blood pressure (SBP) too much due to a lack of myocardial perfusion pressure. We aimed to investigate whether the average achieved SBP <130 mm Hg may cause
-
Bevacizumab-Induced Hypertension in Glioblastoma Patients and Its Potential as a Modulator of Treatment Response. Hypertension (IF 8.3) Pub Date : 2023-06-21 Kaitlin G Scheer,Lisa M Ebert,Michael S Samuel,Claudine S Bonder,Guillermo A Gomez
Glioblastoma invasion is the primary mechanism responsible for its dismal prognosis and is the direct result of interactions between glioblastoma cells and the tumor vasculature. The dysregulated microvasculature in glioblastoma tumors and vessels co-opted from surrounding brain tissue support rapid tumor growth and are utilized as pathways for invasive cancer cells. Attempts to target the glioblastoma
-
Deletion of the Transient Receptor Potential Vanilloid 1 Channel Attenuates Sympathoexcitation and Hypertension and Improves Glomerular Filtration Rate in 2-Kidney-1-Clip Rats. Hypertension (IF 8.3) Pub Date : 2023-06-19 Sean D Stocker,Jacob B Sullivan
BACKGROUND Renal denervation lowers arterial blood pressure in both clinical populations and multiple experimental models of hypertension. This therapeutic effect is partly attributed to the removal of overactive renal sensory nerves. The TRPV1 (transient receptor potential vanilloid 1) channel is highly expressed in renal sensory nerves and detects changes in noxious and mechanosensitive stimuli,
-
Longitudinal Lipidomic Profile of Hypertension in American Indians: Findings From the Strong Heart Family Study. Hypertension (IF 8.3) Pub Date : 2023-06-19 Mingjing Chen,Guanhong Miao,Ying Zhang,Jason G Umans,Elisa T Lee,Barbara V Howard,Oliver Fiehn,Jinying Zhao
BACKGROUND Dyslipidemia is an important risk factor for hypertension and cardiovascular disease. Standard lipid panel cannot reflect the complexity of blood lipidome. The associations of individual lipid species with hypertension remain to be determined in large-scale epidemiological studies, especially in a longitudinal setting. METHODS Using liquid chromatography-mass spectrometry, we repeatedly
-
Potential for a Chat-Based Artificial Intelligence Model to Facilitate Educational Messaging on Hypertension. Hypertension (IF 8.3) Pub Date : 2023-06-16 Edel O'Hagan,Daniel McIntyre,Liliana Laranjo
-
Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE. Hypertension (IF 8.3) Pub Date : 2023-06-15 Felix Mahfoud,Giuseppe Mancia,Roland E Schmieder,Luis Ruilope,Krzysztof Narkiewicz,Markus Schlaich,Bryan Williams,Flavio Ribichini,Joachim Weil,Khaled Almerri,Faisal Sharif,Lucas Lauder,Marianne Wanten,Martin Fahy,Michael Böhm
BACKGROUND The Global SYMPLICITY Registry DEFINE investigates radiofrequency renal denervation (RDN) in a broad range of patients with hypertension. We evaluated whether the number or type of antihypertensive medications were associated with increased long-term blood pressure (BP) reductions and cardiovascular outcomes following radiofrequency RDN. METHODS Patients underwent radiofrequency RDN and
-
Unilaterally Selective Adrenal Vein Sampling for Identification of Surgically Curable Primary Aldosteronism. Hypertension (IF 8.3) Pub Date : 2023-06-15 Gian Paolo Rossi,Domenico Bagordo,Laurence Amar,Michel Azizi,Anna Riester,Martin Reincke,Christoph Degenhart,Jiri Widimsky,Mitsuhide Naruse,Jaap Deinum,Tomaz Kocjan,Ermanno Rossi,Gregory Kline,Akiyo Tanabe,Fumitoshi Satoh,Lars Christian Rump,Oliver Vonend,Peter J Fuller,Jun Yang,Nicholas Yong Nian Chee,Steven B Magill,Zulfiya Shafigullina,Anna Oliveras,Bo-Ching Lee,Chin-Chen Chang,Vin Cent Wu,Zuzana
BACKGROUND Adrenal venous sampling is recommended for the identification of unilateral surgically curable primary aldosteronism but is often clinically useless, owing to failed bilateral adrenal vein cannulation. OBJECTIVES To investigate if only unilaterally selective adrenal vein sampling studies can allow the identification of the responsible adrenal. METHODS Among 1625 patients consecutively submitted
-
Hypertension-A Social Disease in Need of Social Solutions. Hypertension (IF 8.3) Pub Date : 2023-06-14 Jared W Magnani
-
Single-Cell Transcriptome Analysis of Peripheral Neutrophils From Patients With Idiopathic Pulmonary Arterial Hypertension. Hypertension (IF 8.3) Pub Date : 2023-06-14 Rui Zhang,Ji Zhang,Yun-Long Zhang,Su-Gang Gong,Qin-Hua Zhao,Xiao-Juan Wang,Jia-Yu Zhao,Rong Jiang,Hong-Ling Qiu,Hui-Ting Li,Jing He,Shao-Fei Liu,Wolfgang M Kuebler,Lan Wang
BACKGROUND Idiopathic pulmonary hypertension (IPAH) is a rare and devastating disease often accompanied by persistent inflammation and immune responses. We aim to provide a reference atlas of neutrophils to facilitate a better understanding of cellular phenotypes and discovery of candidate genes. METHODS Peripheral neutrophils from naive patients with IPAH and matched controls were profiled. Whole-exon
-
Renin Cells, From Vascular Development to Blood Pressure Sensing. Hypertension (IF 8.3) Pub Date : 2023-06-14 Hiroki Yamaguchi,R Ariel Gomez,Maria Luisa S Sequeira-Lopez
During embryonic and neonatal life, renin cells contribute to the assembly and branching of the intrarenal arterial tree. During kidney arteriolar development renin cells are widely distributed throughout the renal vasculature. As the arterioles mature, renin cells differentiate into smooth muscle cells, pericytes, and mesangial cells. In adult life, renin cells are confined to the tips of the renal
-
Single-Pill Combination Product Availability of the Antihypertensive Regimens Used for Intensive Systolic Blood Pressure Treatment in the Systolic Blood Pressure Intervention Trial. Hypertension (IF 8.3) Pub Date : 2023-06-08 Jordan B King,Catherine G Derington,Jennifer S Herrick,Joshua A Jacobs,Alexander R Zheutlin,Molly B Conroy,William C Cushman,Adam P Bress
BACKGROUND Single-pill combination (SPC) antihypertensive products improve blood pressure control and medication adherence among patients with hypertension. It is unknown to what degree commercially available SPC products could be used to target an intensive systolic blood pressure goal of <120 mm Hg. METHODS This cross-sectional analysis included participants randomized to the intensive treatment
-
Characteristics and Prognosis of Patients With Hypertensive Encephalopathy: A French Nationwide Cohort Study. Hypertension (IF 8.3) Pub Date : 2023-06-07 Jean-Michel Halimi,Jean-Baptiste de Fréminville,Philippe Gatault,Arnaud Bisson,Bénédicte Sautenet,Valentin Maisons,Pascal Vigny,Denis Angoulvant,Laurent Fauchier
BACKGROUND Hypertensive encephalopathy (HE) constitutes a serious condition, usually observed in patients with long-lasting hypertension. Hypertension-associated HE is sometimes differentiated from the stroke-associated hypertensive emergency. Whether prognosis of hypertension-associated and stroke-associated HE is different is unclear. METHODS Characteristics and prognosis of HE were assessed in this
-
Blood Pressure in Children in the 21st Century: What Do We Know and Where Do We Go From Here? Hypertension (IF 8.3) Pub Date : 2023-06-06 Elaine M Urbina,Stephen R Daniels,Alan R Sinaiko
The association between hypertension in adulthood and cardiovascular morbidity and mortality is well known. Based on that association, a diagnosis of elevated blood pressure in children has been clinically interpreted as early cardiovascular disease. The objective of this review is to discuss historical data and new research on the relationship between elevated blood pressure and early preclinical
-
Association Between the Route of Administration and Formulation of Estrogen Therapy and Hypertension Risk in Postmenopausal Women: A Prospective Population-Based Study. Hypertension (IF 8.3) Pub Date : 2023-06-05 Cindy Z Kalenga,Amy Metcalfe,Magali Robert,Kara A Nerenberg,Jennifer M MacRae,Sofia B Ahmed
BACKGROUND Hypertension is the leading global cause of cardiovascular disease and premature mortality in women. The effects of postmenopausal hormone therapy (HT) on blood pressure are uncertain but may be related to route of estrogen administration and formulation of estrogen. We sought to determine the association between route of administration and formulation of estrogen HT and hypertension risk
-
Blood Pressure and Cardiovascular Disease Mortality Among US Adults: A Sex-Stratified Analysis, 1999-2019. Hypertension (IF 8.3) Pub Date : 2023-05-31 Tali Elfassy,Charles A German,Paul Muntner,Eunhee Choi,Gabriel Contreras,Daichi Shimbo,Eugene Yang
BACKGROUND Most research examining the association between blood pressure (BP) and cardiovascular disease (CVD) is sex-agnostic. Our goal was to assess sex-specific associations between BP and CVD mortality. METHODS We combined ten cycles of the National Health and Nutrition Examination Survey (1999-2018), N=53 289. Blood pressure was measured 3× and averaged. Data were linked to National Death Index
-
Systolic Blood Pressure Control Targets to Prevent Major Cardiovascular Events and Mortality in Patients With Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. Hypertension (IF 8.3) Pub Date : 2023-05-31 Qianqian Yang,Ruizhi Zheng,Siyu Wang,Jiamin Zhu,Mian Li,Tiange Wang,Zhiyun Zhao,Min Xu,Jieli Lu,Yuhong Chen,Guang Ning,Weiqing Wang,Yufang Bi,Yu Xu
BACKGROUND Previous meta-analyses using traditional pairwise comparisons did not support intensive systolic blood pressure (SBP) control in patients with diabetes and included trials published before 2015. We aimed to identify the optimal SBP control targets in patients with type 2 diabetes using a systematic review and network meta-analysis of accumulating evidence. METHODS We systematically searched
-
Notch3/Hes5 Induces Vascular Dysfunction in Hypoxia-Induced Pulmonary Hypertension Through ER Stress and Redox-Sensitive Pathways. Hypertension (IF 8.3) Pub Date : 2023-05-31 Hannah E Morris,Karla B Neves,Margaret Nilsen,Augusto C Montezano,Margaret R MacLean,Rhian M Touyz
BACKGROUND Notch3 is implicated in vascular diseases, including pulmonary hypertension (PH)/pulmonary arterial hypertension. However, molecular mechanisms remain elusive. We hypothesized increased Notch3 activation induces oxidative and endoplasmic reticulum (ER) stress and downstream redox signaling, associated with procontractile pulmonary artery state, pulmonary vascular dysfunction, and PH development
-
Trends in Ambulatory Blood Pressure Monitoring in Five High-Volume Medical Centers. Hypertension (IF 8.3) Pub Date : 2023-05-25 Stephen P Juraschek,Natalie A Bello,Alexander R Chang,Jennifer L Cluett,Karen Griffin,Alan Hinderliter,Kenneth Mukamal,Long Ngo,Ruth-Alma N Turkson-Ocran,Raven Voora,Wanpen Vongpatanasin
-
ExoCounter Assays Identify Women Who May Develop Early-Onset Preeclampsia From 12.5 μL First-Trimester Serum by Characterizing Placental Small Extracellular Vesicles. Hypertension (IF 8.3) Pub Date : 2023-05-25 Shuhan Jiang,Wei Zhang,Qing Cao,Maryam Rahbar,William Cooke,Masayuki Ono,Kenichi Fujimaki,Atsushi Saito,Makoto Itonaga,Kenta Oda,Christopher Redman,Manu Vatish
BACKGROUND Preeclampsia is a major cause of maternal and perinatal morbidity and mortality worldwide. Identifying women with high risk of developing preeclampsia in early pregnancy remains challenging. Extracellular vesicles released from the placenta offer an attractive biomarker but have been elusive to quantify. METHODS Here, we tested ExoCounter, a novel device that immunophenotypes size-selected
-
Timing of Antihypertensive Drug Therapy: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Hypertension (IF 8.3) Pub Date : 2023-05-22 Muhammad Haisum Maqsood,Franz H Messerli,Adam H Skolnick,Jonathan D Newman,Jeffrey S Berger,Sripal Bangalore
BACKGROUND The timing of antihypertensive drugs administration is controversial. The aim was to compare the efficacy of dosing of antihypertensive drugs in the morning versus evening. METHODS A PubMed, EMBASE, and clinicaltrials.gov databases search for randomized clinical trials of antihypertensive therapies where patients were randomized to morning versus evening dosing. The outcomes were ambulatory
-
Role of Orthostatic Hypotension in the Development of Dementia in People With and Without Cardiovascular Disease. Hypertension (IF 8.3) Pub Date : 2023-05-19 Xin Xia,Chengxuan Qiu,Debora Rizzuto,Laura Fratiglioni,Lu Dai,Erika J Laukka,Giulia Grande,Davide Liborio Vetrano
BACKGROUND Orthostatic hypotension (OH) has been associated with elevated risk of cardiovascular diseases (CVDs) and dementia risk. To better understand the OH-dementia association, we assessed the associations of OH with CVD and subsequent dementia in older adults and considered the temporality of CVD and dementia onset. METHODS This 15-year population-based cohort study included, at baseline, 2703
-
Childhood Primary Hypertension: Not Uncommon, Not Benign. Hypertension (IF 8.3) Pub Date : 2023-05-17 Susan M Halbach,Joseph T Flynn
-
Tribute to Tadashi Inagami: A Super Legend of Renin Angiotensin II Research. Hypertension (IF 8.3) Pub Date : 2023-05-17 Satoru Eguchi,Masaaki Tamura,Teruyoshi Matoba
-
Team-Based Care With Nonphysician Titration of Antihypertensive Medications in Collaboration With Physicians: A Cost-Effective Way to Control Blood Pressure? Hypertension (IF 8.3) Pub Date : 2023-05-17 Tazeen H Jafar,Rupesh M Shirore
-
Is the First Cut Always the Deepest? Hypertension (IF 8.3) Pub Date : 2023-05-17 Claudio Borghi,Antonio Di Micoli,Giulia Fiorini
-
Assessing the Accuracy of an Online Chat-Based Artificial Intelligence Model in Providing Recommendations on Hypertension Management in Accordance With the 2017 American College of Cardiology/American Heart Association and 2018 European Society of Cardiology/European Society of Hypertension Guidelines. Hypertension (IF 8.3) Pub Date : 2023-05-16 Joseph Kassab,Joseph El Dahdah,Michel Chedid El Helou,Habib Layoun,Ashish Sarraju,Luke J Laffin,Leslie Cho,Samir R Kapadia,Patrick Collier,Serge C Harb
-
Sex Differences in Ambulatory Blood Pressure Levels and Subtypes in a Large Italian Community Cohort. Hypertension (IF 8.3) Pub Date : 2023-05-12 Stefano Omboni,Nadia A Khan,Vijay Kunadian,Agnieszka Olszanecka,Aletta E Schutte,Anastasia S Mihailidou
BACKGROUND Sex differences in blood pressure control are recognized. We systematically investigated sex differences in specific components of ambulatory blood pressure (ABP), including variability, day-night changes, morning surge, and hypertension types. METHODS We analyzed ABPs of 52 911 participants (45.6% male, 54.4% female, 37.0% treated for hypertension) visiting 860 Italian community pharmacies
-
Left Ventricular Mechano-Energetic Efficiency Identifies an Early Impairment of Myocardial Blood Flow in Arterial Hypertension. Hypertension (IF 8.3) Pub Date : 2023-05-12 Maria Lembo,Wanda Acampa,Maria Assunta Elena Rao,Maria Virginia Manzi,Carmine Morisco,Giovanni Esposito,Roberta Assante,Emilia Zampella,Carmela Nappi,Valeria Gaudieri,Teresa Mannarino,Costantino Mancusi,Giovanni de Simone,Raffaele Izzo,Alberto Cuocolo,Bruno Trimarco
BACKGROUND Arterial hypertension causes cardiac functional and structural alterations. In hypertensive patients without flow-limiting epicardial coronary artery disease, we investigated possible relationships between positron emission tomography/computed tomography-derived myocardial blood flow (MBF) and echocardiographic parameters of left ventricular (LV) performance, including mechano-energetic
-
Systematic Review of Therapeutic Agents and Long-Term Outcomes of Familial Hyperaldosteronism Type 1. Hypertension (IF 8.3) Pub Date : 2023-05-12 Shu Ting Tan,Veronica Boyle,Marianne S Elston
BACKGROUND Familial hyperaldosteronism type 1 (FH1), previously known as glucocorticoid-remediable aldosteronism, was the first identified monogenic cause of primary aldosteronism. Patients classically develop hypertension at a young age and are at risk of premature vascular complications. A systematic review of FH1 was performed to determine long-term treatment outcomes. METHODS Using the Preferred
-
Association Between Chronic Hypertension and the Risk of 12 Cardiovascular Diseases Among Parous Women: The Role of Adverse Pregnancy Outcomes. Hypertension (IF 8.3) Pub Date : 2023-05-12 Sukainah Al Khalaf,Lucy C Chappell,Ali S Khashan,Fergus P McCarthy,Éilis J O'Reilly
BACKGROUND Evidence on the association between chronic hypertension and the risk of cardiovascular disease (CVD) in mothers with adverse pregnancy outcomes (APOs) is limited. We investigated the association between chronic hypertension and risk of CVD, considering the role of APOs. METHODS We used linked electronic health records in the CALIBER platform to define a UK cohort of women with recorded
-
High sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Pregnancy-Onset Thrombotic Thrombocytopenic Purpura. Hypertension (IF 8.3) Pub Date : 2023-05-12 Nicolas Béranger,Vassilis Tsatsaris,Paul Coppo,Agnès Veyradier,Bérangère S Joly
-
Visit-to-Visit Blood Pressure Variability and Cardiovascular Outcomes in Patients Receiving Intensive Versus Standard Blood Pressure Control: Insights From the STEP Trial. Hypertension (IF 8.3) Pub Date : 2023-05-12 Jiachen Yu,Qirui Song,JingJing Bai,Shouling Wu,Peili Bu,YuFeng Li,Jun Cai
BACKGROUND The clinical prognostic value of visit-to-visit blood pressure (BP) variability (BPV) is debatable, and relative studies among patients receiving BP control to achieve lower BP targets are limited. METHODS We analyzed a dataset from the STEP trail (Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients) to investigate the relationship between visit-to-visit BPV and
-
Evidence for Age Bias Contributing to Therapeutic Inertia in Blood Pressure Management: A Secondary Analysis of SPRINT. Hypertension (IF 8.3) Pub Date : 2023-05-11 Alexander R Zheutlin,Daniel K Addo,Joshua A Jacobs,Catherine G Derington,Jennifer S Herrick,Tom Greene,Eric L Stulberg,Dan R Berlowitz,Jeff D Williamson,Nicholas M Pajewski,Mark A Supiano,Adam P Bress
BACKGROUND Despite evidence supporting the cardiovascular and cognitive benefits of intensive blood pressure management, older adults have the lowest rates of blood pressure control. We determined the association between age and therapeutic inertia (TI) in SPRINT (Systolic Blood Pressure Intervention Trial), and whether frailty, cognitive function, or gait speed moderate or mediate these associations
-
Shared Heritability of Blood Pressure and Pulse Wave Velocity: Insights From the STANISLAS Cohort. Hypertension (IF 8.3) Pub Date : 2023-05-11 Constance Xhaard,Pierre de Villemereuil,Athanase Benetos,Erwan Bozec,Claire Dandine-Roulland,Edith Le Floch,Véronique Regnault,Patrick Lacolley,Faiez Zannad,Patrick Rossignol,Nicolas Girerd
BACKGROUND Pulse wave velocity (PWV) is a marker of arterial stiffness, which is intrinsically highly correlated with blood pressure (BP). However, the interplay of PWV and BP heritability has not been extensively studied. This study aimed to estimate the heritability of PWV and BP and determine the genetic correlation between PWV and BP. METHODS The heritability of PWV and BP was estimated in 1080
-
Daytime Versus Nighttime Ambulatory Blood Pressure Monitoring in Coarctation of Aorta. Hypertension (IF 8.3) Pub Date : 2023-05-10 Alexander C Egbe,William R Miranda,Heidi M Connolly,Iftikhar J Kullo,Barry A Borlaug
-
Metabolomic Profiles Associated With Blood Pressure Reduction in Response to the DASH and DASH-Sodium Dietary Interventions. Hypertension (IF 8.3) Pub Date : 2023-05-10 Hyunju Kim,Lawrence J Appel,Alice H Lichtenstein,Kari E Wong,Nilanjan Chatterjee,Eugene P Rhee,Casey M Rebholz
BACKGROUND The DASH (Dietary Approaches to Stop Hypertension) diets reduced blood pressure (BP) in the DASH and DASH-Sodium trials, but the underlying mechanisms are unclear. We identified metabolites associated with systolic BP or diastolic BP (DBP) changes induced by dietary interventions (DASH versus control arms) in 2 randomized controlled feeding studies-the DASH and DASH-Sodium trials. METHODS
-
Diffusion-Derived Vessel Density Computed From a Simplified Intravoxel Incoherent Motion Imaging Protocol in Pregnancies Complicated by Early Preeclampsia: A Novel Biomarker of Placental Dysfunction. Hypertension (IF 8.3) Pub Date : 2023-05-10 Junshen He,Chunlin Chen,Liqun Xu,Benheng Xiao,Zhao Chen,Ting Wen,Yì Xiáng J Wáng,Ping Liu
BACKGROUND Early preeclampsia is associated with significant placental hypoperfusion. We explore the diagnostic value of placental diffusion-derived vessel density, a biomarker derived from diffusion-weighted magnetic resonance imaging, which measures in vivo vessel microperfusion, in the differential diagnosis of normal and early preeclampsia pregnancies. METHODS This was a prospective study involving
-
Disconnected Cardiac Autonomic Nerves in Genetic Ganglionic Acetylcholine Receptor Alpha-3 Subunit Deficiency. Hypertension (IF 8.3) Pub Date : 2023-05-10 Karsten Heusser,Florian Erger,Ulrich Ebner,Barbara Namer,Graeme Eisenhofer,Carl-Albrecht Haensch,Henning Weis,Matthias Schmidt,Alexander Drzezga,Jens Tank,Christian Netzer,Jens Jordan
-
Primary Aldosteronism: Spatial Multiomics Mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing Adenomas. Hypertension (IF 8.3) Pub Date : 2023-05-01 Siyuan Gong,Na Sun,Lucie S Meyer,Martina Tetti,Christina Koupourtidou,Stefan Krebs,Giacomo Masserdotti,Helmut Blum,William E Rainey,Martin Reincke,Axel Walch,Tracy Ann Williams
BACKGROUND Primary aldosteronism is frequently caused by an adrenocortical aldosterone-producing adenoma (APA) carrying a somatic mutation that drives aldosterone overproduction. APAs with a mutation in KCNJ5 (APA-KCNJ5MUT) are characterized by heterogeneous CYP11B2 (aldosterone synthase) expression, a particular cellular composition and larger tumor diameter than those with wild-type KCNJ5 (APA-KCNJ5WT)
-
Hypertension in Patients Treated With In-Center Maintenance Hemodialysis: Current Evidence and Future Opportunities: A Scientific Statement From the American Heart Association. Hypertension (IF 8.3) Pub Date : 2023-04-24 Nisha Bansal,Nancy T Artinian,George Bakris,Tara Chang,Jordana Cohen,Jennifer Flythe,Janice Lea,Wanpen Vongpatanasin,Glenn M Chertow,
Nearly 500 000 individuals are treated with maintenance hemodialysis for kidney failure in the United States, and roughly half will die of cardiovascular causes. Hypertension, an important and modifiable risk factor for cardiovascular disease, is observed in >80% of patients treated with maintenance hemodialysis. The pathophysiology of hypertension in patients treated with maintenance hemodialysis
-
Thoracic Spinal Cord Neuroinflammation as a Novel Therapeutic Target in Pulmonary Hypertension. Hypertension (IF 8.3) Pub Date : 2023-04-24 Asif Razee,Somanshu Banerjee,Jason Hong,Shino Magaki,Greg Fishbein,Olujimi A Ajijola,Soban Umar
BACKGROUND Pulmonary hypertension (PH) is associated with aberrant sympathoexcitation leading to right ventricular failure (RVF), arrhythmias, and death. Microglial activation and neuroinflammation have been implicated in sympathoexcitation in experimental PH. We recently reported the first evidence of thoracic spinal cord (TSC) neuroinflammation in PH rats. Here, we hypothesize that PH is associated
-
Hypertension Statistics for US Adults: An Open-Source Web Application for Analysis and Visualization of National Health and Nutrition Examination Survey Data. Hypertension (IF 8.3) Pub Date : 2023-04-21 Byron C Jaeger,Ligong Chen,Kathryn Foti,Shakia T Hardy,Adam P Bress,Sean P Kane,Lei Huang,Jennifer S Herrick,Catherine G Derington,Bharat Poudel,Ashley Christenson,Lisandro D Colantonio,Paul Muntner
BACKGROUND Data from the US National Health and Nutrition Examination Survey are freely available and can be analyzed to produce hypertension statistics for the noninstitutionalized US population. The analysis of these data requires statistical programming expertise and knowledge of National Health and Nutrition Examination Survey methodology. METHODS We developed a web-based application that provides
-
Social Determinants of Health and Uncontrolled Blood Pressure in a National Cohort of Black and White US Adults: the REGARDS Study. Hypertension (IF 8.3) Pub Date : 2023-04-21 Oluwasegun P Akinyelure,Byron C Jaeger,Suzanne Oparil,April P Carson,Monika M Safford,George Howard,Paul Muntner,Shakia T Hardy
BACKGROUND Determining the contribution of social determinants of health (SDOH) to the higher proportion of Black adults with uncontrolled blood pressure (BP) could inform interventions to improve BP control and reduce cardiovascular disease. METHODS We analyzed data from 7306 White and 7497 Black US adults taking antihypertensive medication from the REGARDS (Reasons for Geographic and Racial Differences
-
Potassium: To Add or to Replace…That Is the Question. Hypertension (IF 8.3) Pub Date : 2023-04-19 Mingyu Zhang,Stephen P Juraschek
-
Reducing the Risk of Term Preeclampsia by Risk-Stratified Timing of Birth: Time to Deliver. Hypertension (IF 8.3) Pub Date : 2023-04-19 Ashish Premkumar,Sarosh Rana
-
Exercise and Artery Function in Twins: Sex Differences in a Cross-Over Trial. Hypertension (IF 8.3) Pub Date : 2023-04-19 Daniel J Green,Channa E Marsh,Hannah J Thomas,Leanne Lester,Katrina J Scurrah,Andrew Haynes,Louise H Naylor
BACKGROUND Physical activity reduces cardiovascular risk, partly via direct effects on the arterial wall. We hypothesized that vascular function responses would be modality-specific, sex-dependent, and express a high degree of heritability. METHODS We recruited 90 same-sex twins (31 monozygotic, 14 dizygotic dizygotic pairs; 25.8±6.0 years) and randomized 70 (25 monozygotic, 10 dizygotic) to complete
-
Noise and Air Pollution as Risk Factors for Hypertension: Part I-Epidemiology. Hypertension (IF 8.3) Pub Date : 2023-04-19 Omar Hahad,Sanjay Rajagopalan,Jos Lelieveld,Mette Sørensen,Katie Frenis,Andreas Daiber,Mathias Basner,Mark Nieuwenhuijsen,Robert D Brook,Thomas Münzel
Traffic noise and air pollution are 2 major environmental health risk factors in urbanized societies that often occur together. Despite cooccurrence in urban settings, noise and air pollution have generally been studied independently, with many studies reporting a consistent effect on blood pressure for individual exposures. In the present reviews, we will discuss the epidemiology of air pollution
-
Impact of the Increase in Left Ventricular Mass on the Risk of Long-Term Cardiovascular Mortality: A Prospective Cohort Study. Hypertension (IF 8.3) Pub Date : 2023-04-19 Michele Bombelli,Jennifer Vanoli,Rita Facchetti,Alessandro Maloberti,Cesare Cuspidi,Guido Grassi,Giuseppe Mancia
BACKGROUND Left ventricular hypertrophy (LVH) is an independent predictor of cardiovascular events, and evidence has been obtained that an increase of a normal left ventricular mass (LVM) or new-onset LVH over time augments cardiovascular outcomes. METHODS We addressed this issue in a sample of a general population at relatively low cardiovascular risk. We analyzed subjects with normal echocardiographic
-
Noise and Air Pollution as Risk Factors for Hypertension: Part II-Pathophysiologic Insight. Hypertension (IF 8.3) Pub Date : 2023-04-19 Omar Hahad,Sanjay Rajagopalan,Jos Lelieveld,Mette Sørensen,Marin Kuntic,Andreas Daiber,Mathias Basner,Mark Nieuwenhuijsen,Robert D Brook,Thomas Münzel
Traffic noise and air pollution are environmental stressors found to increase risk for cardiovascular events. The burden of disease attributable to environmental stressors and cardiovascular disease globally is substantial, with a need to better understand the contribution of specific risk factors that may underlie these effects. Epidemiological observations and experimental evidence from animal models